Ramalingam SS - Search Results

1

Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer.

Chmielecki J, Gray JE, Cheng Y, Ohe Y, Imamura F, Cho BC, Lin MC, Majem M, Shah R, Rukazenkov Y, Todd A, Markovets A, Barrett JC, Hartmaier RJ, Ramalingam SS. Chmielecki J, et al. Among authors: ramalingam ss. Nat Commun. 2023 Feb 27;14(1):1070. doi: 10.1038/s41467-023-35961-y. Nat Commun. 2023. PMID: 36849494 Free PMC article.

2

Targeted therapy for the treatment of non-small cell lung cancer: focus on inhibition of epidermal growth factor receptor.

Harichand-Herdt S, Ramalingam SS. Harichand-Herdt S, et al. Among authors: ramalingam ss. Semin Thorac Cardiovasc Surg. 2008 Fall;20(3):217-23. doi: 10.1053/j.semtcvs.2008.09.005. Semin Thorac Cardiovasc Surg. 2008. PMID: 19038731 Review.

3

The role of the taxanes in the treatment of older patients with advanced stage non-small cell lung cancer.

Ramalingam SS, Khuri FR. Ramalingam SS, et al. Oncologist. 2009 Apr;14(4):412-24. doi: 10.1634/theoncologist.2008-0190. Epub 2009 Apr 2. Oncologist. 2009. PMID: 19342473 Free article. Review.

4

Combined inhibition of vascular endothelial growth factor and epidermal growth factor signaling in non-small-cell lung cancer therapy.

Pakkala S, Ramalingam SS. Pakkala S, et al. Among authors: ramalingam ss. Clin Lung Cancer. 2009 Mar;10 Suppl 1:S17-23. doi: 10.3816/CLC.2009.s.003. Clin Lung Cancer. 2009. PMID: 19362942 Review.

5

The role of cetuximab in the management of non-small-cell lung cancer.

Owonikoko TK, Sun SY, Ramalingam SS. Owonikoko TK, et al. Among authors: ramalingam ss. Clin Lung Cancer. 2009 Jul;10(4):230-8. doi: 10.3816/CLC.2009.n.031. Clin Lung Cancer. 2009. PMID: 19632939 Review.

6

Carboplatin and Paclitaxel in combination with either vorinostat or placebo for first-line therapy of advanced non-small-cell lung cancer.

Ramalingam SS, Maitland ML, Frankel P, Argiris AE, Koczywas M, Gitlitz B, Thomas S, Espinoza-Delgado I, Vokes EE, Gandara DR, Belani CP. Ramalingam SS, et al. J Clin Oncol. 2010 Jan 1;28(1):56-62. doi: 10.1200/JCO.2009.24.9094. Epub 2009 Nov 23. J Clin Oncol. 2010. PMID: 19933908 Free PMC article. Clinical Trial.

7

Gender-associated differences in lung cancer: clinical characteristics and treatment outcomes in women.

Harichand-Herdt S, Ramalingam SS. Harichand-Herdt S, et al. Among authors: ramalingam ss. Semin Oncol. 2009 Dec;36(6):572-80. doi: 10.1053/j.seminoncol.2009.10.007. Semin Oncol. 2009. PMID: 19995649 Review.

8

Antiangiogenic agents in the treatment of nonsmall cell lung cancer: reality and hope.

Ramalingam SS, Belani CP. Ramalingam SS, et al. Curr Opin Oncol. 2010 Mar;22(2):79-85. doi: 10.1097/CCO.0b013e328335a583. Curr Opin Oncol. 2010. PMID: 20009926 Review.

9

Phase 2 study of irinotecan and paclitaxel in patients with recurrent or refractory small cell lung cancer.

Ramalingam SS, Foster J, Gooding W, Evans T, Sulecki M, Belani CP. Ramalingam SS, et al. Cancer. 2010 Mar 1;116(5):1344-9. doi: 10.1002/cncr.24753. Cancer. 2010. PMID: 20082454 Free article. Clinical Trial.

10

Maintenance therapy for advanced non-small cell lung cancer: current status, controversies, and emerging consensus.

Owonikoko TK, Ramalingam SS, Belani CP. Owonikoko TK, et al. Among authors: ramalingam ss. Clin Cancer Res. 2010 May 1;16(9):2496-504. doi: 10.1158/1078-0432.CCR-09-2328. Epub 2010 Apr 13. Clin Cancer Res. 2010. PMID: 20388843

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

390 results

Search Page

Filters